D-0883-2017 Class II Terminated
FDA drug recall D-0883-2017 was initiated by Dr. Reddy's Laboratories, Inc. on May 22, 2017 and is designated Class II. Reason for recall: Failed Dissolution Specifications: out of specification results observed for low dissolution. The recall status is terminated (terminated Nov 19, 2018). Affected quantity: 13,221 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 14, 2017
- Initiation Date
- May 22, 2017
- Termination Date
- Nov 19, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13,221 cartons
Product description
Zenatane (isotretinoin) Capsules, USP, 10 mg, 30-count (3 x 10 Prescription Packs) per carton, Rx Only, Manufactured By: Cipla Limited, Kurkumbh Village, Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-135-81
Reason for recall
Failed Dissolution Specifications: out of specification results observed for low dissolution.
Distribution pattern
Nationwide in the USA and Puerto Rico
Code information
Lot #: KB50471, Exp 06/17; KB50710, KB50710A, Exp 08/17; KB60198, Exp 02/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0883-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026